Form 4: Orthopediatrics Corp. Director Acquires Shares

Mark C. Throdahl, a Director at Orthopediatrics Corp., reported the acquisition of 11,436 common shares on June 9, 2026.

Summary

• Mark C. Throdahl, a Director at Orthopediatrics Corp. (KIDS), acquired 11,436 shares of common stock on June 9, 2026.
• Following this transaction, Throdahl beneficially owns 179,317 shares.
• Of the total shares owned, 38,660 are restricted stock awards.
• The acquisition was made at a price of $0 per share, indicating it was likely an award or grant.
• Throdahl also holds 22,497 shares indirectly through a trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine insider transaction without providing new financial or strategic information.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 11,436 shares by a director indicates continued involvement and potential belief in the company's value.
• The total beneficial ownership of 179,317 shares, including restricted stock, suggests a significant stake held by the director.

Future Outlook

No specific forward-looking statements or guidance were provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider transactions, such as this share acquisition by a director, are closely watched by investors as potential indicators of management's confidence in the company's performance and future prospects within the competitive pediatric orthopedics market.

Stakeholder Impact

• Shareholders may view the director's acquisition positively, interpreting it as a sign of confidence in the company's future.
• Employees may see this as a positive indicator of leadership commitment.
• Creditors and suppliers are unlikely to be directly impacted by this insider transaction.

Key Dates

Keywords

Orthopediatrics Corp, KIDS, Form 4, SEC Filing, Insider Trading, Share Acquisition, Director, Beneficial Ownership, Restricted Stock